Where can I learn more about this study?
You can find more information about this study on the websites listed below. If more information about the study results is available, it can also be found here.
> www.clinicaltrials.gov. Once you are on the website, type "NCT02821416" into the search box and click "Search".
www.AstraZenecaClinicalTrials.com. Once you are on the website, type "D3250C00040" into the search box, and click "Find a Study".
Full Study Title: A Double-Blind, Randomized, Parallel Group, Placebo-Controlled Multi-Centre Study to Evaluate the Effect of Benralizumab on Allergen-Induced Inflammation in Mild, Atopic Asthmatics
AstraZeneca AB Protocol Number: D3250C00040
National Clinical Trials number: NCT02821416
AstraZeneca AB sponsored this study and has its headquarters in Södertälje, Sweden.
The thank you!
Clinical study participants belong to a large community of people who take part in clinical research around the world. They help researchers answer important health questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants for clinical studies, nor is it involved in conducting clinical studies.
CISCRP - One Liberty Square, Suite 1100 • Boston, MA 02109 - 1-877-MED-HERO - www.ciscrp.org
Version 1.0 2020_12_17